Weiguo Dai

1.9k total citations · 1 hit paper
23 papers, 1.6k citations indexed

About

Weiguo Dai is a scholar working on Pharmaceutical Science, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Weiguo Dai has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 7 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Weiguo Dai's work include Drug Solubulity and Delivery Systems (11 papers), Protein purification and stability (5 papers) and Analytical Chemistry and Chromatography (4 papers). Weiguo Dai is often cited by papers focused on Drug Solubulity and Delivery Systems (11 papers), Protein purification and stability (5 papers) and Analytical Chemistry and Chromatography (4 papers). Weiguo Dai collaborates with scholars based in United States and China. Weiguo Dai's co-authors include Yanbin Huang, Sen Xu, Dong Liang, W. Mark Saltzman, Yanqiu Song, Shujing Wang, Feng Qian, Shu Li, Tao Hu and Xinyi Zhang and has published in prestigious journals such as Nature Biotechnology, Advanced Drug Delivery Reviews and Applied Catalysis B: Environmental.

In The Last Decade

Weiguo Dai

23 papers receiving 1.5k citations

Hit Papers

Fundamental aspects of solid dispersion technology for po... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiguo Dai United States 20 897 505 428 219 216 23 1.6k
Bo Tang China 20 673 0.8× 329 0.7× 199 0.5× 181 0.8× 86 0.4× 36 1.3k
Vijaykumar Nekkanti United States 13 845 0.9× 350 0.7× 412 1.0× 175 0.8× 153 0.7× 18 1.6k
Thao T.D. Tran Vietnam 30 1.2k 1.4× 633 1.3× 546 1.3× 399 1.8× 131 0.6× 104 2.8k
Chulhun Park South Korea 19 735 0.8× 272 0.5× 295 0.7× 233 1.1× 140 0.6× 63 1.3k
Amber Vyas India 19 781 0.9× 594 1.2× 384 0.9× 355 1.6× 138 0.6× 65 2.0k
Haibing He China 24 884 1.0× 433 0.9× 215 0.5× 258 1.2× 57 0.3× 89 1.7k
M.A. Holgado Spain 21 720 0.8× 166 0.3× 225 0.5× 182 0.8× 126 0.6× 54 1.3k
Bhaskara Jasti United States 24 799 0.9× 393 0.8× 115 0.3× 141 0.6× 69 0.3× 76 1.6k
Dengning Xia China 24 1.1k 1.2× 495 1.0× 258 0.6× 155 0.7× 68 0.3× 44 1.8k
Omer Mustapha Pakistan 16 730 0.8× 478 0.9× 246 0.6× 477 2.2× 61 0.3× 25 1.9k

Countries citing papers authored by Weiguo Dai

Since Specialization
Citations

This map shows the geographic impact of Weiguo Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Dai more than expected).

Fields of papers citing papers by Weiguo Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiguo Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Dai. The network helps show where Weiguo Dai may publish in the future.

Co-authorship network of co-authors of Weiguo Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Weiguo Dai. A scholar is included among the top collaborators of Weiguo Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiguo Dai. Weiguo Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jinjiang, Mary E. Krause, Xiaohong Chen, et al.. (2019). Interfacial Stress in the Development of Biologics: Fundamental Understanding, Current Practice, and Future Perspective. The AAPS Journal. 21(3). 44–44. 121 indexed citations
2.
Wang, Shujing, Guoliang Wu, Xinyi Zhang, et al.. (2017). Stabilizing two IgG1 monoclonal antibodies by surfactants: Balance between aggregation prevention and structure perturbation. European Journal of Pharmaceutics and Biopharmaceutics. 114. 263–277. 49 indexed citations
3.
Dai, Weiguo & Dannong He. (2017). Selective Photoelectrochemical Oxidation of Chiral Ibuprofen Enantiomers. Acta Physico-Chimica Sinica. 33(5). 960–967. 3 indexed citations
4.
Zhang, Ya‐nan, Weiguo Dai, Yuezhong Wen, & Guohua Zhao. (2017). Efficient enantioselective degradation of the inactive (S)-herbicide dichlorprop on chiral molecular-imprinted TiO2. Applied Catalysis B: Environmental. 212. 185–192. 47 indexed citations
5.
Wu, Guoliang, et al.. (2017). Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives. European Journal of Pharmaceutics and Biopharmaceutics. 120. 1–8. 22 indexed citations
6.
Dai, Weiguo, Dong Liang, & Yanqiu Song. (2013). Enhanced bioavailability of poorly absorbed hydrophilic compounds through drug complex/in situ gelling formulation. International Journal of Pharmaceutics. 457(1). 63–70. 12 indexed citations
7.
Huang, Yanbin & Weiguo Dai. (2013). Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharmaceutica Sinica B. 4(1). 18–25. 479 indexed citations breakdown →
8.
Xu, Sen & Weiguo Dai. (2013). Drug precipitation inhibitors in supersaturable formulations. International Journal of Pharmaceutics. 453(1). 36–43. 187 indexed citations
10.
Dai, Weiguo. (2010). In vitro methods to assess drug precipitation. International Journal of Pharmaceutics. 393(1-2). 1–16. 38 indexed citations
11.
Dai, Weiguo, et al.. (2007). Advanced screening assays to rapidly identify solubility-enhancing formulations: High-throughput, miniaturization and automation. Advanced Drug Delivery Reviews. 60(6). 657–672. 48 indexed citations
12.
Dai, Weiguo, et al.. (2007). Combination of Pluronic/Vitamin E TPGS as a potential inhibitor of drug precipitation. International Journal of Pharmaceutics. 355(1-2). 31–37. 57 indexed citations
13.
Dai, Weiguo, Dong Liang, Xinfeng Shi, et al.. (2007). Evaluation of drug precipitation of solubility‐enhancing liquid formulations using milligram quantities of a new molecular entity (NME). Journal of Pharmaceutical Sciences. 96(11). 2957–2969. 53 indexed citations
14.
Dai, Weiguo, Dong Liang, & Yanqiu Song. (2007). Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate. International Journal of Pharmaceutics. 342(1-2). 201–207. 77 indexed citations
15.
Dai, Weiguo, Dong Liang, Shu Li, et al.. (2006). Parallel screening approach to identify solubility-enhancing formulations for improved bioavailability of a poorly water-soluble compound using milligram quantities of material. International Journal of Pharmaceutics. 336(1). 1–11. 32 indexed citations
17.
Shan, Daxian, et al.. (2005). Micrometer-Scale Particle Sizing by Laser Diffraction: Critical Impact of the Imaginary Component of Refractive Index. Pharmaceutical Research. 22(4). 518–522. 24 indexed citations
18.
Dai, Weiguo & W. Mark Saltzman. (1996). Fibroblast aggregation by suspension with conjugates of poly(ethylene glycol) and RGD. Biotechnology and Bioengineering. 50(4). 349–356. 15 indexed citations
19.
Krewson, Christine E., et al.. (1994). Cell aggregation and neurite growth in gels of extracellular matrix molecules. Biotechnology and Bioengineering. 43(7). 555–562. 51 indexed citations
20.
Dai, Weiguo, et al.. (1994). Cell-binding Peptides Conjugated to Poly(ethylene glycol) Promote Neural Cell Aggregation. Nature Biotechnology. 12(8). 797–801. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026